CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- Open-market buys, last 90 days
- $60,455
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$60,455. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-08 | OLUKOTUN ADEOYE Y Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2023-05-08 | Stillwell Richard Newcomb Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2023-05-08 | Taylor Carolyn E. Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2023-05-08 | Treco James Director | Grant or award · Stock Option | +60,000 | 60,000 | ||
| 2023-03-15 | Stillwell Richard Newcomb Director | Grant or award · Stock Option | +83,000 | 83,000 | ||
| 2023-02-23 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +220,000 | 220,000 | ||
| 2023-02-23 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +220,000 | 220,000 | ||
| 2023-02-23 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +200,000 | 200,000 | ||
| 2023-02-23 | SAENGER BRADLEY Chief Financial Officer | Grant or award · Stock Option | +200,000 | 200,000 | ||
| 2023-02-23 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Stock Option | +207,500 | 207,500 | ||
| 2023-02-23 | MORRIS JESSICA EDGAR Chief Operating Officer | Grant or award · Stock Option | +207,500 | 207,500 | ||
| 2023-02-23 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +700,000 | 700,000 | ||
| 2023-02-23 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +700,000 | 700,000 | ||
| 2022-06-29 | LEDERMAN SETH Chief Executive Officer | Purchase | +20,000 | $1.71 | $34K | 24,235 |
| 2022-05-09 | Taylor Carolyn E. Director | Grant or award · Stock Option | +2,131,500 | 2,131,500 | ||
| 2022-05-09 | BAGGER RICHARD H Director | Grant or award · Stock Option | +2,131,500 | 2,131,500 | ||
| 2022-05-09 | Bell Margaret Smith Director | Grant or award · Stock Option | +2,131,500 | 2,131,500 | ||
| 2022-05-09 | GRANGE DAVID L Director | Grant or award · Stock Option | +2,131,500 | 2,131,500 | ||
| 2022-05-09 | OLUKOTUN ADEOYE Y Director | Grant or award · Stock Option | +2,131,500 | 2,131,500 | ||
| 2022-05-09 | Treco James Director | Grant or award · Stock Option | +2,131,500 | 2,131,500 |
Page 5 of 25 · 482 trades